US 9487590
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
granted A61KA61K2039/505A61K47/65
Quick answer
US patent 9487590 (Activatable antibodies that bind interleukin-6 receptor and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K2039/505, A61K47/65